Treeline Biosciences, an…
Treeline Biosciences, an under-the-radar cancer company that has raised more [...]
The FDA has expanded the label for…
The FDA has expanded the label for Pfizer’s Hympavzi, now [...]
Johnson & Johnson has paid $1…
Johnson & Johnson has paid $1 billion upfront to buy [...]
Incyte has struck a deal to buy a…
Incyte has struck a deal to buy a Star Therapeutics [...]
GSK’s latest hepatology…
GSK’s latest hepatology partnership is posing a less-asked question—how do [...]
Roche is paying Nurix Therapeutics…
Roche is paying Nurix Therapeutics $700 million upfront for rights [...]
Even as Zepbound fires on all…
Even as Zepbound fires on all cylinders and Foundayo gets [...]
On the heels of a strong showing…
On the heels of a strong showing for the drug [...]
As the American Diabetes…
As the American Diabetes Association 2026 Scientific Sessions kicked off [...]
The company adjusted its full-year…
The company adjusted its full-year 2025 earnings to account for [...]